• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可卡因是抗精神病药物诱发静坐不能、帕金森综合征和运动障碍的主要风险因素。

Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.

作者信息

Maat Arija, Fouwels Annemarie, de Haan Lieuwe

机构信息

Department of Psychiatry, Academical Medical Center, Amsterdam, The Netherlands.

出版信息

Psychopharmacol Bull. 2008;41(3):5-10.

PMID:18779773
Abstract

OBJECTIVE

To assess the relative contribution of different drugs of abuse to extrapyramidal side effects (EPS) of antipsychotic drugs.

METHOD

106 consecutively contacted or admitted male patients in the Psychiatric Center of Surinam (PCS) with schizophrenia or a related disorder were included. Prevalence and severity of EPS were measured with the Unified Parkinson's Disease Rating Scale (UPDRS), the Abnormal Involuntary Movement rating Scale (AIMS), the Barnes Akathisia Rating Scale (BARS) and the Dystonia rating scale. Recent use of cigarettes, cannabis, alcohol, and cocaine were assessed. Standard multiple regression analyses were used to evaluate the relative contribution of above-mentioned drugs of abuse controlled for milligrams haloperidol equivalent a day and use of anticholinergic medication.

RESULTS

Recent cocaine use was significantly associated with severity of dyskinesia (p = 0.001), parkinsonism (p = 0.007), and akathisia (p < 0.001) (n = 106).

CONCLUSIONS

Recent cocaine use is a major risk factor for antipsychotic induced EPS.

摘要

目的

评估不同滥用药物对抗精神病药物锥体外系副作用(EPS)的相对影响。

方法

纳入了苏里南精神病中心(PCS)106例连续接触或收治的患有精神分裂症或相关疾病的男性患者。采用统一帕金森病评定量表(UPDRS)、异常不自主运动评定量表(AIMS)、巴恩斯静坐不能评定量表(BARS)和肌张力障碍评定量表来测量EPS的患病率和严重程度。评估近期是否使用香烟、大麻、酒精和可卡因。采用标准多元回归分析来评估上述滥用药物在控制每日氟哌啶醇等效毫克数和抗胆碱能药物使用情况下的相对影响。

结果

近期使用可卡因与运动障碍严重程度(p = 0.001)、帕金森症(p = 0.007)和静坐不能(p < 0.001)显著相关(n = 106)。

结论

近期使用可卡因是抗精神病药物所致EPS的主要危险因素。

相似文献

1
Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.可卡因是抗精神病药物诱发静坐不能、帕金森综合征和运动障碍的主要风险因素。
Psychopharmacol Bull. 2008;41(3):5-10.
2
Extrapyramidal side effects and tolerability of risperidone: a review.利培酮的锥体外系副作用及耐受性:综述
J Clin Psychiatry. 1994 May;55 Suppl:29-35.
3
The prevalence of akathisia in patients receiving stable doses of clozapine.接受稳定剂量氯氮平治疗的患者中静坐不能的患病率。
J Clin Psychiatry. 1994 Apr;55(4):142-5.
4
The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.早期氟哌啶醇反应与相关锥体外系副作用之间的关系
J Clin Psychopharmacol. 2017 Feb;37(1):8-12. doi: 10.1097/JCP.0000000000000637.
5
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.在双相躁狂症患者的对照研究中,喹硫平所致锥体外系症状(EPS)的安慰剂水平发生率。
Bipolar Disord. 2006 Oct;8(5 Pt 1):467-74. doi: 10.1111/j.1399-5618.2006.00350.x.
6
Movement disorders associated with neuroleptic treatment.与抗精神病药物治疗相关的运动障碍。
J Clin Psychiatry. 2001;62 Suppl 21:15-8.
7
The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.CYP2D6基因多态性对长期接受抗精神病药物治疗患者的精神病理症状和锥体外系症状的影响。
J Psychopharmacol. 2006 Nov;20(6):829-33. doi: 10.1177/0269881106062894. Epub 2006 Feb 14.
8
Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review.尼斯代尔精神分裂症调查23:运动障碍。20年回顾。
Br J Psychiatry. 2002 Nov;181:422-7. doi: 10.1192/bjp.181.5.422.
9
Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.抗精神病药物锥体外系综合征与患者全因死亡率之间的关系。
Pharmacopsychiatry. 2009 Mar;42(2):57-60. doi: 10.1055/s-0028-1102911. Epub 2009 Mar 23.
10
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.甲氧氯普胺所致迟发性运动障碍和急性锥体外系运动障碍的患病率。
Arch Intern Med. 1993 Jun 28;153(12):1469-75.

引用本文的文献

1
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.单核苷酸多态性作为抗精神病药引起静坐不能的生物标志物:系统评价。
Genes (Basel). 2023 Feb 28;14(3):616. doi: 10.3390/genes14030616.
2
Akathisia after chronic usage of synthetic cathinones: A case study.长期使用合成卡西酮后出现的静坐不能:一项病例研究。
Front Psychiatry. 2022 Dec 23;13:1046486. doi: 10.3389/fpsyt.2022.1046486. eCollection 2022.
3
Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model.慢性可卡因使用者的精神运动症状:一种解释模型。
Int J Environ Res Public Health. 2022 Feb 8;19(3):1897. doi: 10.3390/ijerph19031897.
4
Acute dyskinesia in a patient with schizophrenia.一名精神分裂症患者的急性运动障碍。
BMJ Case Rep. 2018 Dec 9;11(1):e225251. doi: 10.1136/bcr-2018-225251.
5
Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model.利鲁唑通过降低 CREB1 活性减轻 L-DOPA 诱导的异常不自主运动:来自大鼠模型的见解。
Mol Neurobiol. 2019 Jul;56(7):5111-5121. doi: 10.1007/s12035-018-1433-x. Epub 2018 Nov 27.
6
Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.阿立哌唑或利培酮治疗首发精神分裂症的重症患者急性静坐不能的发生率及预测因素:一项观察性研究的二次分析。
Psychopharmacology (Berl). 2019 Feb;236(2):723-730. doi: 10.1007/s00213-018-5101-7. Epub 2018 Nov 15.
7
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.首发非情感性精神病 493 例急性静坐不能的发生率和危险因素:6 周抗精神病药物随机治疗研究。
Psychopharmacology (Berl). 2017 Sep;234(17):2563-2570. doi: 10.1007/s00213-017-4646-1. Epub 2017 May 31.
8
Predictors of community functioning in schizophrenia and substance use disorder patients.精神分裂症和物质使用障碍患者的社区功能预测因素。
Community Ment Health J. 2013 Jun;49(3):317-22. doi: 10.1007/s10597-012-9525-y. Epub 2012 Jul 31.
9
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.精神分裂症和物质使用障碍患者物质使用、神经和精神症状的演变:一项使用喹硫平的为期12周的先导性病例对照试验。
Front Psychiatry. 2011 May 13;2:22. doi: 10.3389/fpsyt.2011.00022. eCollection 2011.
10
Reasons for illicit drug use in people with schizophrenia: Qualitative study.精神分裂症患者使用非法药物的原因:定性研究。
BMC Psychiatry. 2010 Nov 22;10:94. doi: 10.1186/1471-244X-10-94.